Content about Organ transplantation

October 12, 2012

Walmart expands employee healthcare to cover spine, transplant surgery

Walmart has launched a first-of-its-kind Centers of Excellence program that will offer its associates quality health care with no out-of-pocket cost for heart, spine and transplant surgeries at six of the leading hospital and health systems in the United States.

BENTONVILLE, Ark. — Walmart has launched a first-of-its-kind Centers of Excellence program that will offer its associates quality health care with no out-of-pocket cost for heart, spine and transplant surgeries at six of the leading hospital and health systems in the United States.

September 26, 2012

Astellas applies for FDA approval of organ transplant drug

The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

NORTHBROOK, Ill. — The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

Astellas Pharma US said it applied with the FDA for approval of tacrolimus extended-release capsules to prevent rejection of transplanted kidneys in adults and transplanted livers in men. The drug was approved in Europe in 2007 under the name Advagraf and under the name Graceptor in Japan in 2008; the drug has been approved in 69 countries so far.